VistaGen Therapeutics, Inc.
Clinical trials sponsored by VistaGen Therapeutics, Inc., explained in plain language.
A biopharmaceutical company developing therapies for central nervous system disorders.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
Can a nasal spray calm social anxiety? trial ends early
Symptom relief Stopped earlyThis study tested a nasal spray called PH94B to see if it could quickly reduce anxiety in adults with social anxiety disorder during a public speaking task. About 228 participants were expected to take the spray or a placebo before speaking. The trial was terminated early, so res…
Phase 3 • Sponsor: VistaGen Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Social anxiety nasal spray safety trial ends early
Symptom relief Stopped earlyThis study tested the safety of a nasal spray called PH94B for people with social anxiety disorder. Participants used the spray up to 4 times a day for up to 12 months when feeling anxious. The trial was terminated early, so we don't have full results on its safety or effectivene…
Phase 3 • Sponsor: VistaGen Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC